Literature DB >> 9623927

Respiratory syncytial virus infection in tropical and developing countries.

M W Weber1, E K Mulholland, B M Greenwood.   

Abstract

Little is known about the epidemiology of respiratory syncytial virus (RSV) infection in tropical and developing countries; the data currently available have been reviewed. In most studies, RSV was found to be the predominant viral cause of acute lower respiratory tract infections (ALRI) in childhood, being responsible for 27-96% of hospitalised cases (mean 65%) in which a virus was found. RSV infection is seasonal in most countries; outbreaks occur most frequently in the cold season in areas with temperate and Mediterranean climates and in the wet season in tropical countries with seasonal rainfall. The situation on islands and in areas of the inner tropics with perennial high rainfall is less clear-cut. The age group mainly affected by RSV in developing countries is children under 6 months of age (mean 39% of hospital patients with RSV). RSV-ALRI is slightly more common in boys than in girls. Very little information is available about the mortality of children infected with RSV, the frequency of bacterial co-infection, or the incidence of further wheezing after RSV. Further studies on RSV should address these questions in more detail. RSV is an important pathogen ill young children in tropical and developing countries and a frequent cause of hospital admission. Prevention of RSV infection by vaccination would have a significant impact on the incidence of ALRI in children in developing countries.

Entities:  

Mesh:

Year:  1998        PMID: 9623927     DOI: 10.1046/j.1365-3156.1998.00213.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  124 in total

Review 1.  Current research on respiratory viral infections: Third International Symposium.

Authors:  A C Schmidt; R B Couch; G J Galasso; F G Hayden; J Mills; B R Murphy; R M Chanock
Journal:  Antiviral Res       Date:  2001-06       Impact factor: 5.970

2.  Climatic factors and lower respiratory tract infection due to respiratory syncytial virus in hospitalised infants in northern Spain.

Authors:  Santiago Lapeña; Mariá Belén Robles; Leticia Castañón; Juan Pablo Martínez; Sofiá Reguero; María Paz Alonso; Isabel Fernández
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

3.  Molecular analysis of respiratory syncytial virus reinfections in infants from coastal Kenya.

Authors:  Paul D Scott; Rachel Ochola; Mwanajuma Ngama; Emelda A Okiro; D James Nokes; Graham F Medley; Patricia A Cane
Journal:  J Infect Dis       Date:  2005-11-17       Impact factor: 5.226

4.  Respiratory syncytial virus, adenoviruses, and mixed acute lower respiratory infections in children in a developing country.

Authors:  Carlos E Rodríguez-Martínez; Diego Andrés Rodríguez; Gustavo Nino
Journal:  J Med Virol       Date:  2015-02-03       Impact factor: 2.327

5.  Pneumonia case-finding in the RESPIRE Guatemala indoor air pollution trial: standardizing methods for resource-poor settings.

Authors:  Nigel Bruce; Martin Weber; Byron Arana; Anaite Diaz; Alisa Jenny; Lisa Thompson; John McCracken; Mukesh Dherani; Damaris Juarez; Sergio Ordonez; Robert Klein; Kirk R Smith
Journal:  Bull World Health Organ       Date:  2007-07       Impact factor: 9.408

6.  Digital Image Analysis of Cells and Computational Tools for the Study of Mechanism of RSV Entry to Human Bronchial Epithelium.

Authors:  Margarita Gamarra; Eduardo Zurek
Journal:  Sist Tecnol Inf (2017)       Date:  2017-07-13

Review 7.  Detection of respiratory viruses by molecular methods.

Authors:  James B Mahony
Journal:  Clin Microbiol Rev       Date:  2008-10       Impact factor: 26.132

8.  Human Respiratory Syncytial Virus Subtypes A and B Infection Among Children Attending Primary and Secondary Health Care Facilities in Ibadan, Nigeria.

Authors:  O Ogunsemowo; D O Olaleye; G N Odaibo
Journal:  Arch Basic Appl Med       Date:  2018-05-03

9.  Three day versus five day treatment with amoxicillin for non-severe pneumonia in young children: a multicentre randomised controlled trial.

Authors:  Girdhar Agarwal; Shally Awasthi; S K Kabra; Annapurna Kaul; Sunit Singhi; Stephen D Walter
Journal:  BMJ       Date:  2004-03-16

10.  Factors associated with increased risk of progression to respiratory syncytial virus-associated pneumonia in young Kenyan children.

Authors:  Emelda A Okiro; Mwanajuma Ngama; Ann Bett; Patricia A Cane; Graham F Medley; D James Nokes
Journal:  Trop Med Int Health       Date:  2008-05-08       Impact factor: 2.622

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.